Home > Insider Trading > Filing (0001209191-17-038555)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1590560	Uniqure N.v.	QURE	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1693830	Harald Petry	C/O Uniqure N.v. Meibergdreff 61 Amsterdam P7 P7 1005 BA	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2017-03-21	25,422	$3.30	25,422	No	4	M	Direct
Ordinary Shares	Disposition	2017-03-21	25,422	$6.03	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Stock Option (right to buy)	Disposition	2017-03-21	25,422	$0.00	25,422	$3.30

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
115,230		2022-05-04	No	4	M	Direct

Footnotes

The Stock Option was exercised at a price of 3.07 Euros per share. The conversion from Euro to U.S. dollars ($) applied the exchange rate of 1.0737 Euros to U.S. dollars as of the exercise date (the "Exchange Rate").
The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2017.
The shares were sold at a price of 5.6159 Euros per share. The conversion from Euro to U.S. dollars applied the Exchange Rate.
The Stock Option vested in full on February 6, 2014.